By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Is Pharma “Educating” U.S. Patients in the Wrong Way?
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Medical Education > Is Pharma “Educating” U.S. Patients in the Wrong Way?
Medical Education

Is Pharma “Educating” U.S. Patients in the Wrong Way?

Andrew Schorr
Andrew Schorr
Share
5 Min Read
SHARE

medicationsWhat gets patients angry—besides being upset about their diagnosis—is high drug prices. You know the story: elderly people cutting pills and having to make painful choices between taking their medicine as prescribed and paying their rent.

medicationsWhat gets patients angry—besides being upset about their diagnosis—is high drug prices. You know the story: elderly people cutting pills and having to make painful choices between taking their medicine as prescribed and paying their rent. Yes, there are assistance programs, but often people don’t qualify or don’t qualify for enough help. Of course, it is not just the elderly. It presents many families with tough choices.

What rubs salt in the wound? Glossy and frequently broadcast drug company ads on television. These now include efinaconazole (Jublia) for toenail fungus and, incredible to me, a cancer drug for a subset of patients, nivolumab (Opdivo) for lung cancer. We have heard that pharma is now spending $4 billion a year on direct-to-consumer advertising. The U.S. is one of the only countries that allows this. What many patients think is that this money should be used to lower drug costs instead of promoting single products.

As you know, I am in the patient education business, and I am a patient with two cancers myself. One medicine I take is $9,500 a month. That is not uncommon in “chronic cancer” these days. And, in MS, RA and so many other conditions the price is high as well.

More Read

How Staffing Agencies are Helping Healthcare Professionals Land their Dream Jobs
Your Study Path in Nursing: Hardships in Education and How to Overcome Them
Hospital Training Using Virtual World and Avatars
Conference Season Approaching – Prepare for Landing
More From the Nursing Shortage Myth Annals

The industry defends the ads as “education.” But you and I know few health conditions are simple, especially if a patient has multiple conditions or takes multiple medications or has drug allergies. And then, in many conditions, drugs are combined or even used “off label.” The ads do not, and cannot, speak to that. So the truth is the ads oversimplify many health issues. Sure, maybe for erectile dysfunction or toenail fungus the discussion is pretty straightforward but certainly not for cancer. In that area, I would suggest ads are a disservice to the patient. It’s only the ad agencies and TV networks who really benefit.

But don’t take my word for it. Recently the American Medical Association’s Board of Delegates voted to request a ban on DTC advertising of prescription drugs. They welcome “smarter patients” who have a thoughtful discussion with their doctor. But they don’t like the idea of patients simply requesting a product with little understanding of their overall condition or how a single medication may or may not be right for them. So now that a key physician group and many patient leaders are aligned, end the ads. But it’s up to the FDA and Congress to make a ban happen. Shouldn’t they agree?  We can understand why pharma needs money for research to develop new medicines, but we do not understand why they need to spend billions on advertising.

Now I have a better plan: take just 1% of that money and reallocate it to support INDEPENDENT and FAIR and BALANCED education offered by groups like Patient Power, advocacy groups and foundations, and leading medical societies and providers. Right now the support pharma provides for those activities is almost nothing compared to their DTC advertising. And sustained education is clearly needed to help us all take more ongoing responsibility for our health. Step 2 of the plan is to, of course, lower prices.

I believe “smarter patients” who truly understand their condition and the array of products and lifestyle changes that can help is what should be supported, not drumming into our heads a brand name like it is a laundry detergent or toothpaste for “cleaner, whiter teeth and fresher breath.”

Let’s bring on more commercials for island vacations and power drills and bury pharma ads once and for all. Our health and our pocketbook will be better for it.

I welcome your comments!

Best regards,

Andrew

TAGGED:Big Pharmaprescription drugs
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

Epidemiological Health Benefits
Personal and Epidemiological Health Benefits of Blood Pressure Management
Health
October 13, 2025
Traumatic Brain Injuries
Understanding Traumatic Brain Injuries: What Families Need to Know
Policy & Law
October 10, 2025
Remote Monitoring touchpoints
Remote Monitoring Touchpoints Patients Will Actually Follow
Technology
October 9, 2025
dental care
Importance of Good Dental Care for Health and Confidence
Dental health Specialties
October 2, 2025

You Might also Like

BHG Partner, Operation Smile
FinanceMedical EducationPublic HealthWellness

From Lake Placid: Doc Generously Donates Surgeries, Resources

October 20, 2015

Emergency Nurses: An Overabundance of Violence

November 11, 2015

Video Player is Updated With New Videos!

January 19, 2012
biopharma beat incremental change healthcare
Medical EducationMedical InnovationsPublic HealthTechnologyWellness

BioPharma Beat: Incremental Innovation Is Sometimes What the Doctor Needs

September 16, 2014
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?